Suppr超能文献

p62/SQSTM1——兼具抗氧化应激作用与促肝癌作用的“杰ekyll博士与海德先生”。 (注:这里“杰ekyll博士与海德先生”是用文学形象比喻p62/SQSTM1具有两种不同甚至相反特性的复杂情况 )

p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.

作者信息

Taniguchi Koji, Yamachika Shinichiro, He Feng, Karin Michael

机构信息

Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, University of California San Diego, La Jolla, CA, USA.

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

FEBS Lett. 2016 Aug;590(15):2375-97. doi: 10.1002/1873-3468.12301. Epub 2016 Aug 6.

Abstract

p62/SQSTM1 is a multifunctional signaling hub and autophagy adaptor with many binding partners, which allow it to activate mTORC1-dependent nutrient sensing, NF-κB-mediated inflammatory responses, and the NRF2-activated antioxidant defense. p62 recognizes polyubiquitin chains via its C-terminal domain and binds to LC3 via its LIR motif, thereby promoting the autophagic degradation of ubiquitinated cargos. p62 accumulates in many human liver diseases, including nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC), where it is a component of Mallory-Denk bodies and intracellular hyaline bodies. Chronic p62 elevation contributes to HCC development by preventing oncogene-induced senescence and death of cancer-initiating cells and enhancing their proliferation. In this review, we discuss p62-mediated signaling pathways and their roles in liver pathophysiology, especially NASH and HCC.

摘要

p62/SQSTM1是一个多功能信号枢纽和自噬衔接蛋白,有许多结合伴侣,使其能够激活mTORC1依赖性营养感知、NF-κB介导的炎症反应以及NRF2激活的抗氧化防御。p62通过其C末端结构域识别多聚泛素链,并通过其LIR基序与LC3结合,从而促进泛素化货物的自噬降解。p62在许多人类肝脏疾病中积累,包括非酒精性脂肪性肝炎(NASH)和肝细胞癌(HCC),它是马洛里-丹克小体和细胞内透明小体的组成部分。长期p62升高通过防止癌基因诱导的衰老和癌症起始细胞死亡并增强其增殖,促进HCC的发展。在这篇综述中,我们讨论了p62介导的信号通路及其在肝脏病理生理学中的作用,尤其是在NASH和HCC中的作用。

相似文献

1
p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.
FEBS Lett. 2016 Aug;590(15):2375-97. doi: 10.1002/1873-3468.12301. Epub 2016 Aug 6.
2
p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells.
Cancer Cell. 2016 Jun 13;29(6):935-948. doi: 10.1016/j.ccell.2016.04.006. Epub 2016 May 19.
3
p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities.
FEBS J. 2023 Feb;290(4):892-912. doi: 10.1111/febs.16317. Epub 2021 Dec 18.
5
p62/SQSTM1 functions as a signaling hub and an autophagy adaptor.
FEBS J. 2015 Dec;282(24):4672-8. doi: 10.1111/febs.13540. Epub 2015 Oct 16.
6
Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy.
Mol Cell. 2013 Sep 12;51(5):618-31. doi: 10.1016/j.molcel.2013.08.003. Epub 2013 Sep 5.
7
Role of p62/SQSTM1 in liver physiology and pathogenesis.
Exp Biol Med (Maywood). 2013 May;238(5):525-38. doi: 10.1177/1535370213489446.
8
SQSTM1/p62 and Hepatic Mallory-Denk Body Formation in Alcohol-Associated Liver Disease.
Am J Pathol. 2023 Oct;193(10):1415-1426. doi: 10.1016/j.ajpath.2023.02.015. Epub 2023 Mar 9.
9
Hepatocellular carcinomas with intracellular hyaline bodies have a poor prognosis.
Liver Int. 2017 Apr;37(4):600-610. doi: 10.1111/liv.13325. Epub 2017 Jan 12.
10
Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma.
Expert Opin Ther Targets. 2019 May;23(5):393-406. doi: 10.1080/14728222.2019.1601703. Epub 2019 Apr 15.

引用本文的文献

1
Assessing Autophagy Activation in Advanced Ovarian Cancer Using Ascitic Fluid: A Feasibility Study.
Cureus. 2025 Feb 20;17(2):e79371. doi: 10.7759/cureus.79371. eCollection 2025 Feb.
2
NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance.
Front Immunol. 2025 Jan 30;16:1518664. doi: 10.3389/fimmu.2025.1518664. eCollection 2025.
5
How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy.
J Food Drug Anal. 2023 Aug 31;31(3):387-407. doi: 10.38212/2224-6614.3463.
6
Targeting regulated cell death pathways in cancers for effective treatment: a comprehensive review.
Front Cell Dev Biol. 2024 Nov 15;12:1462339. doi: 10.3389/fcell.2024.1462339. eCollection 2024.
7
SERPINH1 modulates apoptosis by inhibiting P62 ubiquitination degradation to promote bone metastasis of prostate cancer.
iScience. 2024 Jul 10;27(8):110427. doi: 10.1016/j.isci.2024.110427. eCollection 2024 Aug 16.
8
Protective Effects of Hepatocyte Stress Defenders, Nrf1 and Nrf2, against MASLD Progression.
Int J Mol Sci. 2024 Jul 24;25(15):8046. doi: 10.3390/ijms25158046.
9
Mechanistic Insights and Potential Therapeutic Implications of NRF2 in Diabetic Encephalopathy.
Mol Neurobiol. 2024 Oct;61(10):8253-8278. doi: 10.1007/s12035-024-04097-5. Epub 2024 Mar 14.
10
Autophagy impairment in human bile duct carcinoma cells.
Front Physiol. 2023 Sep 29;14:1249264. doi: 10.3389/fphys.2023.1249264. eCollection 2023.

本文引用的文献

1
SQSTM1/p62 mediates crosstalk between autophagy and the UPS in DNA repair.
Autophagy. 2016 Oct 2;12(10):1917-1930. doi: 10.1080/15548627.2016.1210368. Epub 2016 Jul 8.
4
p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA.
Oncogene. 2017 Jan 19;36(3):304-317. doi: 10.1038/onc.2016.202. Epub 2016 Jun 27.
5
Autophagy Regulates Chromatin Ubiquitination in DNA Damage Response through Elimination of SQSTM1/p62.
Mol Cell. 2016 Jul 7;63(1):34-48. doi: 10.1016/j.molcel.2016.05.027. Epub 2016 Jun 23.
6
Sequestosome 1/p62 Protein Is Associated with Autophagic Removal of Excess Hepatic Endoplasmic Reticulum in Mice.
J Biol Chem. 2016 Sep 2;291(36):18663-74. doi: 10.1074/jbc.M116.739821. Epub 2016 Jun 20.
7
Measuring Autophagy in the Context of Cancer.
Adv Exp Med Biol. 2016;899:121-43. doi: 10.1007/978-3-319-26666-4_8.
8
Depletion of autophagy receptor p62/SQSTM1 enhances the efficiency of gene delivery in mammalian cells.
FEBS Lett. 2016 Aug;590(16):2671-80. doi: 10.1002/1873-3468.12262. Epub 2016 Jul 4.
9
The Dual Roles of NRF2 in Cancer.
Trends Mol Med. 2016 Jul;22(7):578-593. doi: 10.1016/j.molmed.2016.05.002. Epub 2016 Jun 2.
10
Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas.
Oncotarget. 2016 Jun 28;7(26):39241-39255. doi: 10.18632/oncotarget.9649.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验